Nektar Therapeutics (NKTR) Files $300M Mixed Shelf
Tweet
Share
E-mail
Get Alerts NKTR Hot Sheet
Join SI Premium – FREE
Nektar Therapeutics (NASDAQ: NKTR) has filed $300,000,000 mixed shelf of:
Common Stock
Preferred Stock
Debt Securities
Warrants
Units
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- Vista Gold names Gavin Ferguson as managing director in Australia
- Guggenheim Reiterates Buy Rating on Bristol-Myers Squibb Co. (BMY)
Create E-mail Alert Related Categories
Corporate News, Equity OfferingsRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
